Dyadic Receives U.S. Patent for Manufacturing Seasonal and Pandemic Influenza Vaccines from its Proprietary C1 Protein Production Platform
18. April 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
10. August 2022 16:00 ET
|
Dyadic International, Inc.
Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support clinical safety of proteins produced from...
AZN INVESTOR NOTICE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important March 29 Deadline in Securities Class Action – AZN
18. März 2021 20:15 ET
|
The Rosen Law Firm PA
NEW YORK, March 18, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and...
BREAKING NEWS: ROSEN, NATIONAL TRIAL COUNSEL, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline – AZN
10. Februar 2021 17:30 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and...
SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Reminds Investors of Pending Securities Class Action Lawsuit against AstraZeneca plc and Encourages Investors to Inquire About the Lead Plaintiff Position Before the March 29, 2021 Lead Plaintiff Deadline
04. Februar 2021 16:51 ET
|
Lowey Dannenberg, P.C.
NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a federal securities class action...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites AstraZeneca (AZN) Investors to Contact Firm, Securities Fraud Case Related to Potential COVID-19 Treatment Filed
28. Januar 2021 15:50 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges AstraZeneca PLC (NASDAQ: AZN) investors to submit their losses now. A securities fraud lawsuit has been filed and certain...
SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Announces Filing of Securities Class Action Lawsuit Against AstraZeneca plc on Behalf of Investors Who Acquired Shares from May 21, 2020 to November 20, 2020 and Encourages Investors to Inquire About the Lead Plaintiff Position Before the March 29, 2021 Lead Plaintiff Deadline
28. Januar 2021 13:23 ET
|
Lowey Dannenberg, P.C.
NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a federal securities class action...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Alexion Pharmaceuticals, Inc. Buyout
14. Dezember 2020 18:20 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Alexion Pharmaceuticals, Inc. (“Alexion”) (NASDAQ GS: ALXN) regarding possible...